Skip to main content

Development of a Set of EBV-Specific Antigens with Recombinant Gene Technology for Diagnosis of EBV-Related Malignant or Nonmalignant Diseases

  • Chapter
Epstein-Barr Virus and Human Disease

Part of the book series: Experimental Biology and Medicine ((EBAM,volume 15))

Abstract

Epstein-Barr virus (EBV) serology can be considerably improved when pure defined antigens are used and antibody class specific tests are applied (1, 2). The identification of antigens is possible by series of Western blots and immunoprecipitations (3). In combination with gene mapping data from hybrid-selected translation (3, 4), recombinant DNA technology was used to produce a panel of viral antigens. These antigens were evaluated in antibody class specific tests in their diagnostic significance for infectious mononucleosis, chronic active EBV infection and nasopharyngeal carcinoma (NPC).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Zhu, X.X., Zeng, Y., Wolf, H. Int. J. Cancer 37, 689–691 (1986).

    Article  PubMed  CAS  Google Scholar 

  2. Pi, G.H., Zeng, Y., Wolf, H. J. virol. Methods (1986) in press.

    Google Scholar 

  3. Wolf, H. et al. Contr. Oncol. 24. (Karger Verlag, Basel, 1986) in press.

    Google Scholar 

  4. Seibl, R., Wolf, H. Virology 141, 1–13 (1985).

    Article  PubMed  CAS  Google Scholar 

  5. Motz, M., Fan, J., Seibl, R., Jilg, W., Wolf, H. Gene 42, 303–312 (1986).

    Article  PubMed  CAS  Google Scholar 

  6. Jilg, W., Wolf, H. J. Infect. Diseases 152, 222–225 (1985).

    Article  CAS  Google Scholar 

  7. Straus, S.E. et al. Ann. Inter. Med. 102, 7–16 (1985).

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 The Humana Press Inc.

About this chapter

Cite this chapter

Wolf, H. et al. (1987). Development of a Set of EBV-Specific Antigens with Recombinant Gene Technology for Diagnosis of EBV-Related Malignant or Nonmalignant Diseases. In: Levine, P.H., Ablashi, D.V., Nonoyama, M., Pearson, G.R., Glaser, R. (eds) Epstein-Barr Virus and Human Disease. Experimental Biology and Medicine, vol 15. Humana Press. https://doi.org/10.1007/978-1-4612-4590-2_39

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-4590-2_39

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-4612-8940-1

  • Online ISBN: 978-1-4612-4590-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics